Last Thursday we saw a tale of two biotech companies. If you need evidence investing in medical research stocks is a lottery, this is the story for you.First we have Sirtex Medical, a Sydney-based company that provides radioactive treatment to help extend the lives of patients suffering from liver cancers.Its shares jumped 28 per cent after it revealed stronger-than-expected results […]
by Tony BoydJust when Australia’s beaten-down biotech sector was in need of a boost, Silviu Itescu at stem cell pioneer Mesoblast sends positive signals by selling $58.5 million in stock to US pharmaceutical giant, Celgene Corporation.This is a hugely important transaction for Mesoblast and the Australian biotech sector. It shows big pharma is not content to sit back and rely on […]
Brian RobinsWhat a difference a year makes. The downturn in mining stocks from 2013 saw hot money flow into the biotech sector. But after some spectacular research failures, sentiment soured, leaving the sector firmly in the shadows for much of 2014 so that even the surge in biotech stocks globally bypassed the local players.Alchemia, QRx Pharma and Prana were all […]
